• 1
    Scosyrev E, Yao J, Messing E. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice. Urology 2010; 76: 90813
  • 2
    Bastian PJ, Hutterer GC, Shariat SF et al. Bladder Cancer Research Consortium. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int 2008; 101: 4504
  • 3
    Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 244858
  • 4
    von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 306877
  • 5
    Quek ML, Stein JP, Clark PE et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 2004; 171: 6405
  • 6
    Boudreaux KJ Jr, Chang SS, Lowrance WT et al. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 2009; 115: 7705
  • 7
    Sonpavde G, Khan MM, Svatek RS et al. Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. J Urol 2011; 185: 121621
  • 8
    Advanced Bladder. Cancer (ABC) Meta-analysis collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 2005; 48: 189201
  • 9
    Lebret T, Mejean A. Metastases from urothelial carcinoma: role of chemotherapy. Prog Urol 2008; 18 (Suppl. 7): S26176
  • 10
    Advanced Bladder Cancer Meta-analysis Collaboration. WITHDRAWN: neoadjuvant cisplatin for advanced bladder cancer. Cochrane Database Syst Rev 2011; (6): CD001426
  • 11
    Wosnitzer MS, Hruby GW, Murphy AM et al. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer. Cancer 2012; 118: 35864
  • 12
    Matsumoto K, Soh S, Satoh T et al. Distribution of lymphatic vessel network in normal urinary bladder. Urology 2008; 72: 70610
  • 13
    Marchetti C, Poggi P, Farina A, Gritti A, Scelsi L, Scelsi R. Structure of the initial lymphatics of the human urinary bladder with invasive urothelial tumors. Lymphology 1996; 29: 11825
  • 14
    Jass JR, Barker M, Fraser L et al. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 2003; 56: 6973
  • 15
    Méjean A, Lebret T. Metastatic diffusion, angiogenesis and metastasogenesis. Prog Urol 2010; 20 (Suppl. 1): S510
  • 16
    Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 2011; 364: 212837
  • 17
    Goossens-Laan CA, Gooiker GA, van Gijn W et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 77583